GCG and prediabetes syndrome: In the prediabetes group, treatment with linagliptin 5 mg once-daily for 12 weeks significantly reduced HbA1c from baseline in the high GLP-1 group [LS-mean change from baseline -0.33% (95% CI -0.48, -0.18).